My Size Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

My Size wird voraussichtlich ein Umsatzwachstum verzeichnen at 8.5% per annum.

Wichtige Informationen

n/a

Wachstumsrate der Gewinne

n/a

EPS-Wachstumsrate

Software Gewinnwachstum	17.1%
Wachstumsrate der Einnahmen	8.5%
Zukünftige Eigenkapitalrendite	n/a
Analystenabdeckung	Low
Zuletzt aktualisiert	18 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Gewinn- und Umsatzwachstumsprognosen

NasdaqCM:MYSZ - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2025	11	N/A	N/A	N/A	1
12/31/2024	9	N/A	N/A	N/A	1
9/30/2024	10	-5	-4	-4	N/A
6/30/2024	10	-4	-5	-5	N/A
3/31/2024	9	-5	-5	-5	N/A
12/31/2023	7	-6	-6	-6	N/A
9/30/2023	7	-7	-6	-6	N/A
6/30/2023	5	-8	-7	-7	N/A
3/31/2023	5	-9	-7	-7	N/A
12/31/2022	4	-8	-7	-7	N/A
9/30/2022	2	-9	-9	-9	N/A
6/30/2022	1	-9	-9	-9	N/A
3/31/2022	0	-11	-9	-9	N/A
12/31/2021	0	-11	-7	-7	N/A
9/30/2021	0	-10	-6	-6	N/A
6/30/2021	0	-9	-6	-6	N/A
3/31/2021	0	-6	-6	-6	N/A
12/31/2020	0	-6	-6	-6	N/A
9/30/2020	0	-6	-5	-5	N/A
6/30/2020	0	-5	-6	-6	N/A
3/31/2020	0	-5	-6	-6	N/A
12/31/2019	0	-5	-6	-5	N/A
9/30/2019	0	-5	-5	-5	N/A
6/30/2019	0	-5	-4	-4	N/A
3/31/2019	0	-2	-4	-4	N/A
12/31/2018	N/A	-6	-4	-4	N/A
9/30/2018	N/A	-7	-4	-4	N/A
6/30/2018	N/A	-7	N/A	-4	N/A
3/31/2018	N/A	-9	N/A	-4	N/A
12/31/2017	N/A	-5	N/A	-4	N/A
9/30/2017	N/A	-4	N/A	-3	N/A
6/30/2017	N/A	-4	N/A	-3	N/A
3/31/2017	N/A	-6	N/A	-3	N/A
12/31/2016	N/A	-4	N/A	-2	N/A
9/30/2016	N/A	-5	N/A	-2	N/A
6/30/2016	N/A	-6	N/A	-2	N/A
3/31/2016	N/A	-3	N/A	-2	N/A
12/31/2015	N/A	-3	N/A	-1	N/A
9/30/2015	N/A	-3	N/A	-1	N/A
6/30/2015	N/A	-2	N/A	-1	N/A
3/31/2015	N/A	-1	N/A	-1	N/A
12/31/2014	N/A	0	N/A	-1	N/A
9/30/2014	N/A	-1	N/A	-1	N/A
6/30/2014	N/A	0	N/A	0	N/A
3/31/2014	N/A	0	N/A	0	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: Unzureichende Daten, um festzustellen, ob das prognostizierte Gewinnwachstum von MYSZ über der Sparquote liegt (2.6%).

Ertrag vs. Markt: Unzureichende Daten, um festzustellen, ob die Gewinne von MYSZ schneller wachsen werden als der Markt US

Hohe Wachstumserträge: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von MYSZ in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: MYSZDie Einnahmen des Unternehmens (8.5% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.9% pro Jahr).

Hohe Wachstumseinnahmen: MYSZDie Einnahmen des Unternehmens (8.5% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von MYSZ in 3 Jahren voraussichtlich hoch sein wird

My Size Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

My Size, Inc. Revises Revenue Guidance for the Full Year Ended December 31, 2023

My Size, Inc. Reiterates Revenue Guidance for the Year 2023

My Size, Inc. Provides Earnings Guidance for the Year 2022

My Size, Inc. Reiterates Revenue Guidance for 2022

My Size, Inc. Reiterates Earnings Guidance for the Year 2022

Recent updates

Third quarter 2024 earnings released: US$1.25 loss per share (vs US$3.54 loss in 3Q 2023)

My Size, Inc., Annual General Meeting, Dec 30, 2024

Insufficient new directors

Second quarter 2024 earnings released: US$1.28 loss per share (vs US$4.23 loss in 2Q 2023)

First quarter 2024 earnings released: US$1.89 loss per share (vs US$13.42 loss in 1Q 2023)

My Size Regains Compliance with Nasdaq Minimum Closing Bid Price Rule

My Size Approves 1-for-8 Reverse Stock Split to Regain Compliance with the Continued Listing Requirements of Nasdaq

Full year 2023 earnings released: US$2.50 loss per share (vs US$7.47 loss in FY 2022)

MySize, Inc. to Showcase FirstLook Smart Mirror and Digital Sizes Solutions at National Retail Federation's NRF 2024 Retail's Big Show

Third quarter 2023 earnings released: US$0.44 loss per share (vs US$1.98 loss in 3Q 2022)

My Size, Inc., Annual General Meeting, Dec 27, 2023

My Size Receives Non-Compliance Notice from Nasdaq Regarding Non-Compliance with the Minimum Bid Price Requirements Set Forth in Nasdaq Listing Rule 5550(a)(2) for Continued Listing on The Nasdaq Capital Market

My Size Receives Non-Compliance Notice From Nasdaq

Mysize's Naiz Fit Launches New Product for $33 Billion Workwear & Uniforms Market

My Size, Inc. Revises Revenue Guidance for the Full Year Ended December 31, 2023

My Size, Inc. to Report Q3, 2023 Results on Nov 15, 2023

Mysize's Naiz Fit Smart Catalogue Uses AI to Solve Major Challenge of Fit in the Jeans Industry

New minor risk - Share price stability

Second quarter 2023 earnings released: US$0.53 loss per share (vs US$1.69 loss in 2Q 2022)

New major risk - Financial position

My Size, Inc. Reiterates Revenue Guidance for the Year 2023

Full year 2022 earnings released: US$7.47 loss per share (vs US$17.75 loss in FY 2021)

MySize, Inc. Receives Notice of Patent Allowance in Canada for AI & Algorithm-Driven Measurement Solution

My Size, Inc. announced that it expects to receive $1.649999 million in funding

My Size Regains Compliance with Nasdaq Minimum Closing Bid Price Rule

My Size, Inc. Provides Earnings Guidance for the Year 2022

My Size, Inc., Annual General Meeting, Dec 07, 2022

My Size, Inc. (TASE:MYSZ) acquired Naiz Bespoke Technologies Sl for $500,000 in cash and 6 million shares of MySize common stock.

MySize acquires Spain's Naiz Fit

MySize gains 8.7% premarket on JV with Brazilian firm Santista Têxtil

My Size, Inc. Reiterates Revenue Guidance for 2022

MySize surges 47% on higher quarterly revenue

MySize Receives Nasdaq Listing Extension

MySize gets extension to meet Nasdaq's minimum bid price rule

First quarter 2022 earnings released: US$0.088 loss per share (vs US$0.16 loss in 1Q 2021)

My Size, Inc. Reiterates Earnings Guidance for the Year 2022

Mysize Inc. Launches Firstlook Smart Mirror, the Ultimate Omnichannel Solution for Retailers

My Size, Inc. Appoints Ezequiel Javier Brandwain as Chief Commercial Officer

My Size Not in Compliance with Minimum Bid Price Requirements Set Forth in Nasdaq Listing Rule 5550(A)(2)

Third quarter 2021 earnings released: US$0.13 loss per share (vs US$0.23 loss in 3Q 2020)

Insider recently sold US$125k worth of stock

My Size, Inc. Rolls Out New Rewards Program, Offering Perks for Making More Eco-Friendly, Better Fitting Purchases

Second quarter 2021 earnings released: US$0.33 loss per share (vs US$0.25 loss in 2Q 2020)

Custodian Ventures Delivers Open Letter To My Size Stockholders

My Size, Inc. Developing Sizing Solution for Pre Owned Apparel

Custodian Ventures Delivers Letter to My Size

Insider recently bought US$336k worth of stock

My Size, Inc. Announces Grant of European Patent for Handheld Measurement Tech

MySize to Provide Unparalleled Avatar Try-On Experience for Online Apparel Shoppers

Full year 2020 earnings released: US$1.11 loss per share (vs US$2.75 loss in FY 2019)

My Size, Inc. Launches SDK Solution Targeting E-Commerce Market with Fully-Customizable Plugin

New 90-day high: US$1.71

Datalogic Partners With MySize, Expanding the Availability of the Deliver Solution BoxSize™

My Size shares down 15% after pricing equity offering

MySize delivers over 12M size recommendations in 2020

New 90-day high: US$1.50

My Size, Inc to Add Highly Accurate Online Footwear Sizing to Ecommerce Solution

My Size, Inc. Announces Partnership with UniformMarket, Significantly Expanding Their Presence in Workwear

MySize collaborates with UniformMarket for workwear space expansion

New 90-day high: US$1.15

Third quarter 2020 earnings released: US$0.23 loss per share

My Size, Inc. Launches Custom Clothing Made-to-Measure Feature for MySizeID

New 90-day low: US$0.93

My Size, Inc. Integrating Mysizeid into E-Commerce Platform of Tricorp

New 90-day low - US$1.02

Earnings released

Gewinn- und Umsatzwachstumsprognosen

Analystenprognosen zum zukünftigen Wachstum

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite